Related Experiment Video
Updated: Aug 18, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Dimerize RACK1 upon transformation with oncogenic ras
Ling-Yun Chu1, Yu-Hsun Chen, Nin-Nin Chuang
1Institute of Zoology, National Taiwan University, Taipei, Taiwan.
Abstract:
From our previous studies, we learned that syndecan-2/p120-GAP complex provided docking site for Src to prosecute tyrosine kinase activity upon transformation with oncogenic ras. And, RACK1 protein was reactive with syndecan-2 to keep Src inactivated, but not when Ras was overexpressed. In the present study, we characterized the reaction between RACK1 protein and Ras. RACK1 was isolated from BALB/3T3 cells transfected with plasmids pcDNA3.1-[S-ras(Q61K)] of shrimp Penaeus japonicus and RACK1 was revealed to react with GTP-K(B)-Ras(Q61K), not GDP-K(B)-Ras(Q61K). This selective interaction between RACK1 and GTP-K(B)-Ras(Q61K) was further confirmed with RACK1 of human placenta and mouse RACK1-encoded fusion protein. We found that RACK1 was dimerized upon reaction with GTP-K(B)-Ras(Q61K), as well as with 14-3-3beta and geranylgeranyl pyrophosphate, as revealed by phosphorylation with Src tyrosine kinase. We reported the complex of RACK1/GTP-K(B)-Ras(Q61K) reacted selectively with p120-GAP. This interaction was sufficient to dissemble RACK1 into monomers, a preferred form to compete for the binding of syndecan-2. These data indicate that the reaction of GTP-K(B)-Ras(Q61K) with RACK1 in dimers may operate a mechanism to deplete RACK1 from reaction with syndecan-2 upon transformation by oncogenic ras and the RACK1/GTP-Ras complex may provide a route to react with p120-GAP and recycle monomeric RACK1 to syndecan-2.
Insights
Oncogenic Ras transformation disrupts RACK1 binding to syndecan-2 by promoting RACK1 dimerization with GTP-Ras. This mechanism depletes RACK1, allowing Src kinase activity and cell transformation.
Area of Science:
- Molecular Cell Biology
- Oncogenesis
- Signal Transduction
Background:
- Previous studies identified the syndecan-2/p120-GAP complex as a docking site for Src tyrosine kinase activity during oncogenic Ras transformation.
- RACK1 protein normally interacts with syndecan-2 to maintain Src inactivation, but this interaction is disrupted by Ras overexpression.
Purpose of the Study:
- To characterize the specific interaction between RACK1 protein and Ras.
- To elucidate the mechanism by which oncogenic Ras disrupts the RACK1-syndecan-2 interaction.
Main Methods:
- Isolation of RACK1 from BALB/3T3 cells transfected with oncogenic Ras plasmids.
- Confirmation of RACK1 interaction with GTP-bound Ras (GTP-K(B)-Ras(Q61K)) using various RACK1 sources (shrimp, human, mouse).
- Analysis of RACK1 dimerization and its interaction with p120-GAP using Src tyrosine kinase phosphorylation assays.
Main Results:
- RACK1 selectively binds to GTP-bound Ras, not GDP-bound Ras.
- RACK1 dimerizes upon binding to GTP-Ras, 14-3-3beta, and geranylgeranyl pyrophosphate.
- The RACK1/GTP-Ras complex interacts with p120-GAP, leading to RACK1 monomerization and subsequent competition for syndecan-2 binding.
Conclusions:
- Oncogenic Ras transformation induces RACK1 dimerization with GTP-Ras, effectively sequestering RACK1 and preventing its interaction with syndecan-2.
- This RACK1 sequestration mechanism allows for sustained Src tyrosine kinase activity, promoting cell transformation.
- The RACK1/GTP-Ras complex facilitates interaction with p120-GAP, potentially recycling monomeric RACK1 to syndecan-2.
More Related Videos
10:27Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation